The group's principal activity is to provide reference laboratory services to the pharmaceutical and diagnostics industries. The group had developed non-invasive technologies for use in diagnostics to improve the detection and management of chronic diseases. The group developed two new patented platform technologies developed to permit the use of sweat and saliva as diagnostic fluids. Salivasac(R) collects a non-invasive saliva sample that is used to replace blood and urine testing in various applications.
